- Ørsted projects its 2026 EBITDA, excluding items, to be between DKK 29 billion and DKK 33 billion.
- The company plans to cut its 2030 investment program by approximately 25%.
- They are facing challenges with their US offshore wind portfolio.
- Ørsted plans an investment program valued between DKK 210 billion and DKK 230 billion for the period 2024-2030.
- They have discontinued their previous ambition of achieving 35-38 GW installed renewable capacity by 2030 and the target EBITDA of approximately DKK 39-43 billion, excluding new partnerships, for 2030.
- Ørsted maintains a target to reinstate dividends starting from the financial year 2026.
- Market analyst ratings include 14 buys, 20 holds, and 1 sell recommendation for Ørsted.
“`
A look at Orsted AS Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Orsted A/S, a company providing utility services, has received varied Smart Scores across different factors. While the company has a strong Value score, indicating favorable valuation metrics, it lags behind in Dividend, Resilience, and Momentum scores. With a modest Growth score, Orsted shows potential for future expansion but faces challenges in dividend payouts, resilience to market fluctuations, and sustaining momentum in its operations.
Despite a mixed outlook based on the Smart Scores, Orsted A/S remains focused on developing, constructing, and operating offshore wind farms. With a global customer base, the company’s emphasis on renewable energy aligns with the growing trend towards sustainability. Investors considering Orsted should weigh the company’s strong value proposition against its weaker performance in dividends, resilience, and momentum indicators to make informed long-term investment decisions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
